Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,9516720,half-life,"In conscious sodium replete sheep with a parotid fistula, infusion of CBX (40 mg/h for 10 days) did not increase mean arterial pressure, or change sodium and potassium status or plasma renin concentration, but significantly increased the half-life of 1,2[3H] cortisol from 18.6 +/- 4.0 to 38.8 +/- 3.9 min (p < 0.05) and reduced the blood clearance rate of cortisol (BCR) from 31 +/- 3 to 15 +/- 4 L/h (p < 0.01).",Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9516720/),min,18.6,230574,DB02329,Carbenoxolone
,9516720,half-life,"In conscious sodium replete sheep with a parotid fistula, infusion of CBX (40 mg/h for 10 days) did not increase mean arterial pressure, or change sodium and potassium status or plasma renin concentration, but significantly increased the half-life of 1,2[3H] cortisol from 18.6 +/- 4.0 to 38.8 +/- 3.9 min (p < 0.05) and reduced the blood clearance rate of cortisol (BCR) from 31 +/- 3 to 15 +/- 4 L/h (p < 0.01).",Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9516720/),min,38.8,230575,DB02329,Carbenoxolone
,9516720,blood clearance rate of cortisol (BCR),"In conscious sodium replete sheep with a parotid fistula, infusion of CBX (40 mg/h for 10 days) did not increase mean arterial pressure, or change sodium and potassium status or plasma renin concentration, but significantly increased the half-life of 1,2[3H] cortisol from 18.6 +/- 4.0 to 38.8 +/- 3.9 min (p < 0.05) and reduced the blood clearance rate of cortisol (BCR) from 31 +/- 3 to 15 +/- 4 L/h (p < 0.01).",Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep. ,CLb-Q23,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9516720/),[l] / [h],31,230576,DB02329,Carbenoxolone
,9516720,blood clearance rate of cortisol (BCR),"In conscious sodium replete sheep with a parotid fistula, infusion of CBX (40 mg/h for 10 days) did not increase mean arterial pressure, or change sodium and potassium status or plasma renin concentration, but significantly increased the half-life of 1,2[3H] cortisol from 18.6 +/- 4.0 to 38.8 +/- 3.9 min (p < 0.05) and reduced the blood clearance rate of cortisol (BCR) from 31 +/- 3 to 15 +/- 4 L/h (p < 0.01).",Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep. ,CLb-Q23,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9516720/),[l] / [h],15,230577,DB02329,Carbenoxolone
,9516720,secretion rate,The reduction in cortisol BCR was associated with reduction in cortisol secretion rate from 433 +/- 116 to 181 +/- 79 nmol/h (p < 0.01).,Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9516720/),[nM] / [h],433,230578,DB02329,Carbenoxolone
,9516720,secretion rate,The reduction in cortisol BCR was associated with reduction in cortisol secretion rate from 433 +/- 116 to 181 +/- 79 nmol/h (p < 0.01).,Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9516720/),[nM] / [h],181,230579,DB02329,Carbenoxolone
